The Department of Health of the Philippines allegedly ignored experts' recommendations on the rollout of the controversial Dengvaxia immunization program. Instead of the vaccine protecting children against the dengue virus, the recipients now carry greater risk.
Public Health December 11, 2017
Earlier recommendations greenlighted administration of Sanofi's Dengvaxia in healthy individuals to prevent dengue fever. Findings of a new long-term study, however, found the dengue vaccine could pose risk to certain individuals.
Medicine December 4, 2017
The dengue vaccine currently used in about six countries could make people sick rather than protect them if not used appropriately. Researchers advise that the vaccine should be used depending on the infection rate of the locality.
Public Health September 3, 2016
Researchers injected participants with an experimental vaccine for the dengue virus, finding that it was 100 percent effective.
LIFE March 16, 2016
Researchers launched a large-scale clinical trial participated by 17,000 individuals to test a dengue vaccine. The Phase 3 trial will be conducted in Brazil, which saw more than 1.5 million dengue cases in 2015 alone.
LIFE January 16, 2016
Following Mexico's approval, Philippines' Department of Health has confirmed the use of Dengvaxia, a vaccine that can prevent all forms of the disease particularly dengue hemorrhagic fever which strikes hundreds of millions each year. India is also expected to approve the Dengvaxia vaccine soon.
LIFE December 28, 2015
According to the World Health Organization, dengue fever has now become a global threat. Climate change and globalization have spurred this disease to spread worldwide.
LIFE December 23, 2015
Mexican health officials approved the world's first dengue vaccine manufactured by Sanofi Pasteur. Dengvaxia reduces hospitalization risks by 80 percent based on global clinical tests and also lowers the chances of developing dengue's most severe form by 93 percent.
LIFE December 10, 2015
Latest study has found that an experimental vaccine against dengue may be more effective in older children compared to the younger ones. The researchers based their study on hospitalization rates after the third dose of the vaccine was administered.
LIFE July 28, 2015